Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Fukuda

Showing results (41-50 of 233) with videos related to

Pageof 24
Sort By:
Journal of Medical Economics|December 20, 2013
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in JapanAtaru Igarashi, Kaori Fujito, Masaharu Hirano, et al.
Pharmacoeconomics|March 27, 2016
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in JapanHaruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
QALY and productivity loss: empirical evidence for "double counting"Takeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
The Journal of Antibiotics|April 29, 2004
New beauvericins, potentiators of antifungal miconazole activity, Produced by Beauveria sp. FKI-1366. II. Structure elucidationTakashi Fukuda, Masayoshi Arai, Hiroshi Tomoda, et al.
Health Policy (Amsterdam, Netherlands)|July 9, 2017
New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluationsTakeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Cost Effectiveness and Resource Allocation : C/E|October 17, 2013
WTP for a QALY and health states: More money for severer health states?Takeru Shiroiwa, Ataru Igarashi, Takashi Fukuda, et al.
Biomicrofluidics|July 24, 2020
An on-demand bench-top fabrication process for fluidic chips based on cross-diffusion through photopolymerizationTakumi Kimoto, Kou Suzuki, Takashi Fukuda, et al.
The Journal of Antibiotics|May 15, 2020
2-Epi-anthracimycin, a new cytotoxic agent from the marine-derived actinomycete Streptomyces sp. OPMA00631Takashi Fukuda, Kenichiro Nagai, Akihiko Kanamoto, et al.
Journal of Gastrointestinal Oncology|March 12, 2026
Risk factors and prognostic implications of upper or middle mediastinal lymph nodes metastasis and recurrence in esophagogastric junction carcinomaShintaro Nozu, Takashi Fukuda, Shinichiro Shiomi, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|October 5, 2019
Sex Differences in Iliotibial Band Strain under Different Knee AlignmentsDa Yoon Kim, Shumpei Miyakawa, Takashi Fukuda, et al.
Pageof 24

Showing results (41-50 of 233) with videos related to

Sort By:
Pageof 24
Journal of Medical Economics|December 20, 2013
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in JapanAtaru Igarashi, Kaori Fujito, Masaharu Hirano, et al.
Pharmacoeconomics|March 27, 2016
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in JapanHaruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
QALY and productivity loss: empirical evidence for "double counting"Takeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
The Journal of Antibiotics|April 29, 2004
New beauvericins, potentiators of antifungal miconazole activity, Produced by Beauveria sp. FKI-1366. II. Structure elucidationTakashi Fukuda, Masayoshi Arai, Hiroshi Tomoda, et al.
Health Policy (Amsterdam, Netherlands)|July 9, 2017
New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluationsTakeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Cost Effectiveness and Resource Allocation : C/E|October 17, 2013
WTP for a QALY and health states: More money for severer health states?Takeru Shiroiwa, Ataru Igarashi, Takashi Fukuda, et al.
Biomicrofluidics|July 24, 2020
An on-demand bench-top fabrication process for fluidic chips based on cross-diffusion through photopolymerizationTakumi Kimoto, Kou Suzuki, Takashi Fukuda, et al.
The Journal of Antibiotics|May 15, 2020
2-Epi-anthracimycin, a new cytotoxic agent from the marine-derived actinomycete Streptomyces sp. OPMA00631Takashi Fukuda, Kenichiro Nagai, Akihiko Kanamoto, et al.
Journal of Gastrointestinal Oncology|March 12, 2026
Risk factors and prognostic implications of upper or middle mediastinal lymph nodes metastasis and recurrence in esophagogastric junction carcinomaShintaro Nozu, Takashi Fukuda, Shinichiro Shiomi, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|October 5, 2019
Sex Differences in Iliotibial Band Strain under Different Knee AlignmentsDa Yoon Kim, Shumpei Miyakawa, Takashi Fukuda, et al.
Pageof 24